Overview

A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

Status:
Completed
Trial end date:
2019-11-13
Target enrollment:
Participant gender:
Summary
In this study, researchers were primarily interested in evaluating the level of agreement of cooling sensation provided by this chewable, flavored, allergy medicine. Participants joining this study received one test drug tablet and were asked to chew completely before swallowing the drug. A questionnaire was used to collect the feedback from participants. The study involved only one (1) visit and participant stayed in this study for about 60-75 minutes to evaluate the cooling sensation as well as other sensory attributes perceived in the mouth, nose and throat.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Loratadine